Gray, Glenda

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 2,397

Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection

Dunkle, K. L., Jewkes, R. K., Brown, H. C., Gray, G. E., McIntryre, J. A., & Harlow, S. D. (2004) · Social Science & Medicine

Sex work and related issuesHIV/AIDS Research and Interventions

Cited by 566

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Corey, L., Gilbert, P. B., Juraska, M., Montefiori, D. C., Morris, L., Karuna, S. T., Edupuganti, S., Mgodi, N. M., deCamp, A. C., Rudnicki, E., et al. (2021) · New England Journal of Medicine

HIV Research and TreatmentHIV/AIDS Research and Interventions

Cited by 538

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., Mujugira, A., Baeten, J. M., Mullins, J. I., Hughes, J. P., et al. (2010) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHerpesvirus Infections and Treatments

Cited by 524

Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition

Jamison, D. T., Alwan, A., Mock, C. N., Nugent, R., Watkins, D., Adeyi, O., Anand, S., Atun, R., Bertozzi, S., Bhutta, Z., et al. (2018) · The Lancet

Healthcare Systems and ReformsHealthcare Systems and Practices

Cited by 227

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa

Collie, S., Nayager, J., Bamford, L., Bekker, L.-G., Zylstra, M., & Gray, G. (2022) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 97

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.

Delany-Moretlwe, S., Lombard, C., Baron, D., Bekker, L.-G., Nkala, B., Ahmed, K., Sebe, M., Brumskine, W., Nchabeleng, M., Palanee-Philips, T., et al. (2018) · The Lancet Infectious Diseases

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 95